throbber
DONALD VOET
`University of Pennsylvania
`
`JUDITH G. VOET
`Swarthmore College
`
`BIOCHEMISTRY
`
`SECOND EDITION
`
`JOHN WILEY & SONS, INC.
`
`Page 1 of 8
`
`AstraZeneca Exhibit 2092
`Mylan v. AstraZeneca
`IPR2015-01340
`
`

`
`Cover Art: Two paintings of horse heart cytochrome c by
`Irving Geis in which the protein is illuminated by its sin-
`gle iron atom. On the front cover the hydrophilic side
`chains are drawn in green, and on the back cover the by-
`drophobic side chains are drawn in orange. The paintings
`are based on an X-ray structure by Richard Dickerson.
`
`Acquisitions Editor: Neda}: Rose
`Marketing Manager: (‘aflwrinc Fadmka
`Designen Madelyn l..esure
`Manufacturing Manager: Susan Stctzer
`Photo Researcher: Hilary Newman
`illustration Coordinator: Edward Starr
`Illustrators: J/B WrmI.t'L'_t' A.t'.t'0t.'iatc.t‘
`Production Management: Pamela Kwmed ' Oborski and
`Suzanne lngrao
`Cover and Part Opening Illustrations © Irving Get’:
`This book was set in 9.5/I2 Times Roman by Progressive
`Information Technologies and printed and bound by
`Von Hoffman Press. The cover was printed by Lehigh
`Press Lithographers. Color separations by Lehigh Press
`Colortronics.
`
`Recognizing the importance of preserving what has been written, it is a policy of John Wiley &
`Sons, Inc. to have books of enduring value published in the United States printed on acid-free
`paper, and we exert our best efforts to that end.
`
`Copyright © 1995. by John Wiley & Sorts. Inc.
`
`All rights reserved. Published simultaneously in Canada.
`
`Reproduction or translation of any part of
`this work beyond that permitted by Sections
`I07 and 108 of the I976 United States Copyright
`Act without the permission or the copyright
`owner is unlawful. Requests for permission
`or further information should be addressed to
`the Pen-nissions Department. John Wiley & Sons. Inc.
`
`ISBN: 0-471-586st-x
`
`Printed in the United States of America
`
`I09
`
`Page 2 of 8
`
`

`
`Introduction to
`Enzymes
`
`1. Historical Perspective
`2. Substrate Specificity
`A. Stcreospecificity
`B. Geometric Specificity
`3. Cocnzymes
`
`4. Regulation of Enzymatic Activity
`5. A Primer of Enzyme Nomenclature
`
`The enormous variety of biochemical reactions that com-
`prise life are nearly all mediated by a series of remarkable
`biological catalysts known as enzymes. Although enzymes
`are subject to the same laws of nature that govern the be-
`havior ofother substances, they difl'er from ordinary chem-
`ical catalysts in several important respects:
`
`1. Higher reaction rates: The rates of enzymatically cata-
`lyzed reactions are typically factors of 10‘ to IO" greater
`than those of the corresponding uncatalyzed reactions
`and are at least several orders ofmagnitudc greater than
`those of the corresponding chemically catalyzed reac-
`trons.
`
`2. Milder reaction conditions: Enzymatically catalyzed re-
`actions occur under relatively mild conditions: temper-
`atures below l00°C, atmospheric pressure, and nearly
`neutral pH's. ln contrast, eflicient chemical catalysis
`often requires elevated temperatures and pressures as
`well as extremes of pH.
`3. Greater reaction specificity: Enzymes have a vastly
`greater degree ofspecificity with respect to the identities
`of both their substrates (reactants) and their products
`than do chemical catalysts; that is, enzymatic reactions
`
`.
`rarely have side products. For example. in the cnzy .;
`synthesis of proteins on ribosomes (Section 30-3), po ‘
`peptides consisting of well over I000 amino acid 7
`dues are made all but error free. Yet, in the che I»;
`synthesis ofpolypeptides, nde reactions and incom -.
`reactions presently limit the lengths of polypeptides ,
`can be accurately produced in reasonable yields to~l
`residues (Section 643).
`
`'
`
`-
`-
`Capacity for regulation: The catalytic activities of -
`enzymes vary in response to the concentrations of su
`stances other than their substrates. The mechanisms
`these regulatory processes include allosteric control. ‘_
`valcnt modification of enzymes, and variation of x
`amounts of enzymes synthesized.
`
`_‘
`
`-
`
`Consideration of these remarkable catalytic pr0P°T"‘5.
`enzymes leads to one ofthe central questions ofbi _
`‘I .
`try: How do enzymes work? We address this issue in '
`part of the text.
`In this chapter, following a historical review, WC "'
`mence our study ofenzyms with a discussion ofM0‘ "
`instances of enzyme action: one that illustrates 110"’ '3
`zyme specificity is manifested, and a second that 0“ ‘
`hes the regulation of enzyme activity. These ill’? b’.
`means exhaustive treatments but are intended I0 _l"3hl
`these all-important aspects of enzyme mechanlifl"
`shall encounter numerous other examples of IN“ ,«
`nomena in our study of metabolism (Chapt€fS_ '5,’
`These two expositions are interspersed with a confldegp l
`ofthc role ofenzymatic cofactors. The chapter end’ 13 a
`short synopsis ofenzyme nomenclature. In ChIlP"' S
`.
`take up the formalism ofcnzyme kinetics because W‘ V»
`of the rates of enzymatically catalyzed reactions Pm”
`indispensable mechanistic information. Finally» Ch
`POWE ‘
`
`,
`
`Page 3 of 8
`
`

`
`4 is a general discussion ofthe catalytic mechanisms em-
`loycd by enzymes, followed by an examination of the
`h;|l'llSl'l‘l5 ofseveral specific enzymes.
`P
`met
`
`1' HISTORICAL PERSPECTIVE
`
`The early history of enzymology, the study ofcnzyrnes, is
`largely that ofbiochemistry itself; ‘these disciplines evolved
`gogether from nineteenth century investigations offennen-
`“(ion and digestion. Research on fermentation is widely
`considered to have begun in l8l0 with Joseph Gay-Lus-
`,3¢'s determination that ethanol and C0, are the principal
`ucls of sugar decomposition by yeast. in 1835, Jacob
`Bflzglius, in the lirst general theory of chemical catalysis,
`poimed out that an extract ofmalt known as diastase (now
`known to contain the enzyme er-amylase; Section 10-2D)
`analyzes the hydrolysis ofstarch more etliciently than does
`sulfuric acid. Yet, despite the ability of mineral acids to
`mimic the elfect ofdiastase. it was the inability to reproduce
`most other biochemical reactions in the laboratory that led
`Louis Pasteur, in the mid-nineteenth century, to propose
`mat the processes of fennentation could only occur in liv-
`ing cells Thus, as was common in his era, Pasteur assumed
`that living systems were endowed with a “vital force" that
`permitted them to evade the laws ofnature governing inan-
`imate mattcr. Others, however. notably Justus Liebig, ar-
`gued that biological processes are caused by the action of
`chemical substances that were then known as “l'ern1ents.”
`Indeed. the name "enzyme" (Greek: en. in + zymc. yeast)
`
`Section 1.’-2. Substrate Specificity 333
`
`Although the subject of enzyinology has a long history.
`most ofour understanding of the nature and functions of
`enzymes is a product ofthe latter halfofthe twentieth cen-
`tury. Only with the advent ofmodern techniques for sepa-
`ration and analysis (Chapter 5) has the isolation and char-
`acterization ofan enzyme become less than a monumental
`task. It was not until I 963 that the iirst amino acid sequence
`of an enzyme, that of bovine pancreatic ribonuclease A
`(Section I4-IA), was reported in its entirety, and not until
`I965 that the first X-ray structure ofan enzyme, that olhen
`egg white lysozyine (Section I4-ZA), was elucidated. In the
`years since then, several thousan
`'
`lied and characterized to at least some extent and the pace
`of this endeavor is rapidly accelerating.
`
`2. SUBSTRATE SPECIFICITY
`
`The noticevalentjbrces through which mbstrates andother
`molecules bindto enzymes are identical in character (0 the
`forces that dictate the conformation: ofthe proteins them-
`selves (Section 7-4): Both involve van der Waals, electro-
`static, hydrogen bonding. and hydrophobic interactions. In
`general. a substrate—binding site consists of an indentation
`or clefl on the surface of an enzyme molecule that is com-
`plementary in shape to the substrate (geometrical comple-
`mentarity). Morcover, the amino acid residues that form
`the binding site are arranged to interact specifically with the
`substrate in an attractive manner (electronic complemen-
`tarity; Fig 12-1). Molecules that difl‘er in shape or func-
`
`the yeast itself, that catalyzes the reactions offermentation.
`Nevertheless. it was not until I897 that Eduard Buchner
`obtained a cell-free yeast extract that could carry out the
`synthesis ofelhanol from glucose (alcoholic fermentation;
`Section I6-3B).
`Emil Fischer’: discovery,
`Zltmes can distinguish betwee
`lbe fomtulation ofhis lock-and-key hypothesis: Thespeci-
`ficityofan enzyme(theIockjforitssubstrate(theIcey)arises
`from their geometrical!y complementary shapes. Yet, the
`<-jhemical composition of enzymes was not fumly estab-
`lished until well into the twentieth century. In I92 ,
`ho crystallized the liist enzyme, jack
`"59. which catalyzes the hydrolysis of urea to NH, and
`onstrated that these crystals consist of protein.
`mner's preparations were somewhat impure, how-
`
`“fa Ogical experiencesince then hasamplydemonstrated
`' °"2Ymes are proteins (although it has recently been
`Isl.:’_"’" thatsomespeciesofRNAalsohavecatalyticproper-
`» Section 29-4B).
`
`Page 4 of 8
`
`

`
`334 Chapter 12. Introduction to Enzymes
`
`tional group distribution from the substrate cannot produc-
`tively bind to the enzyme; that is,
`they cannot fonn
`enzyme-substrate complexes that lead to the formation or
`products. The substrate-binding site may, in accordance
`with the lock-and-key hypothesis, exist in the absence of
`bound substrate or it may. as suggested by the induced fit
`hypothesis (Section 9-4C), form about the substrate as it
`binds to the enzyme. X-Ray studies indicate that the sub
`strate-binding sites ofmost enzymes are largely preformed
`but that most of(Item exhibit at least some degreeofinduced
`fit upon binding substrate.
`
`A. Stereospecificity
`
`Enzymes are highly specific both in binding chiral sub-
`strates and in catalyzing their reactions. This stereospeci-
`ficity arises because enzymes, by virtue of their inherent
`chiraiity (proteins consist of only L-amino acids), form
`asymmetric active sites. For example, trypsin readily hy-
`drolyzes polypeptides composed of L-amino acids but not
`those consisting of D-amino acids. Likewise, the enzymes
`involved with glucose metabolism (Section I6-2) are spe-
`cific for o-glucose residues.
`
`Enzynros are absolutely stercospecijrc in the rcactiom
`they catalyze. This was strikingly demonstrated for the case
`of yeast alcohol dehydrogenase (YADH) by Frank West.
`heimer and Birgit Vennesland. Alcohol dehydrogenase cat-
`alyaes the interconversion ofethanol and acetaldehyde ac.
`cording to the reaction:
`
`0
`
`h +
`I
`wmrr
`+
`CH;.CH,Ol-I + NAD «ti CH,.CH + NADH + II
`Ethanol
`Acotnldohydc
`
`The structures of NAD* and NADH are presented in Fig,
`12-2. Ethanol, it will be recalled, isa prochiral molecu|e(sc¢
`Section 4-2C for a discussion of prochirality):
`
`9H
`
`Plprrr-S .1 —'H[It'r» It
`
`CH3
`
`Ethanol’s two methylene H atoms may be distinguished if
`the molecule is held in some sort ofasymmetric jig (Fig.
`12-3). The substrate-binding sites ofenzymes are, oft:0ur.rc,
`
`Oxidized lorrn
`
`Reduced form
`
`OH
`
`ll
`
`Nicotinurnidc
`
`r,
`Iii
`I
`\+..,.N
`
`M ti
`\
`
`o
`.(‘L
`
`Nil: + 11*
`
`-{fa NH,
`
`2f
`
`-1» 2In.r=‘
`
`J’
`
`\ N
`
`Aden osi no
`
`.\
`R
`
`II
`l’()
`
`Nicotinnmido adenine dinuclcotidc (NA.D"')
`Nicotitmtnidc adenine dlnucleotitlc phosphate (NADl"”)
`
`FIGURE I2-2. The structures and reactions ofnicotinamlde
`adenine dinucleotide (NA D*) and nicotinamide adenine
`dinuclcotide phosphate (NADP*). Their reduced forms are
`NADH and NADPH. [In the older literature they are termed
`tllphosphopyridine nucleotide (DPN*) and triphosphopyridine
`nucleotide ('l'PN*) and their reduced forms are symbolized
`DPNH and TPNI-L] These substances. which are collectively
`
`.
`referred to as the nicotinarnidc eoenzymes or pyridine
`nucleotides (nicotinamide is a pyridine derivative) l‘unction_. "5 '5
`indicated in later chapters, as intracellular carriers of reducIIlB_
`equivalents (electrons). Note that only the nicotinumidc l'll'|9 '5
`changed in the reaction. Reduction formally involves the
`transfer of two hydrogen atoms (H - ), although the actual
`reduction may occur via a different mechanism.
`
`Page 5 of 8
`
`

`
`Section I2-2. Stibxtratcspmjficity 335
`
`is quantitatively transferred from the NADD to the acet-
`aldehyde to fonn the product ethanol:
`
`O
`n
`CHQCH + |
`
`ll
`
`I)
`\.
`
`|
`
`’l‘n
`
`0
`II
`C‘Nn,
`'
`
`YADH
`+ 11* -.——-—-‘
`
`on
`
`1|--(1:-I) + NAB’
`
`EH3
`
`3. ifthe enantiomer of the foregoing CH,CI-IDOH is made
`as follows:
`
`0"
`0
`3
`+ man
`II
`(‘I~l,,CD + NADI-I + H ; D'-Q'-'H + NAD
`
`+
`
`c'H;.
`
`none of the deuterium is transferred from the product
`ethanol to NAD* in the reverse reaction.
`4. If, however, this ethanol is converted to its tosylate and
`then inverted by SN2 hydrolysis to yield the enantio-
`meric ethanol,
`
`p -Tolucncsulfonyl
`chloride
`(tosyl chloride)
`
`CH3
`
`I-lC‘l
`
`CH3
`
`_L
`
`4»
`
`IO
`
`+
`
`H
`
`II
`
`0 l
`
`D C‘H
`IC
`
`“J
`
`o—c—H
`
`en,
`
`the deuterium is again quantitatively transfened to
`NAD" in the YADH reaction.
`
`The foregoing observations. in addition to showing that
`there is direct hydrogen transfer in the YADH reaction
`(Experiments I and 2), indicate that the enzyme distin-
`guishes between the pro-S and pro-R hydrogens of ethanol
`as well as the st’ and re faces of the nicotinamide ring of
`NAD* (Experiments 2-4). It was later demonstrated, by
`stereospecific syntheses, that YADH transfers the pro-R
`
`12-3. The specific attachment of a prochiral center
`,9 an enzyme-binding site permits the enzyme to diflcrentiate
`. mum pt-ochiral groups.
`
`-.,
`‘
`
`,3‘
`.w
`
`just such jigs since they immobt'lt':e the reacting groups of
`the .Subslra(t.' on the enzyme surface.
`Weslhcimcr and Vennesland elucidated the stereospe-
`cihc nature of the YADH reaction through the following
`series of experiments:
`
`1. If the YADH reaction is carried out with deuterated
`ethanol. the product NADH is deuterated:
`
`0 3
`
`H
`
`\ \N"-.-
`/
`
`NAn*
`
`CH1?“ OH
`
`+
`
`0
`’l
`
`D I!
`\‘
`
`O
`ll
`(‘x
`
`cumn + [f:H/ N“:+H+
`NI
`R
`
`N
`NADD
`ch‘?'°ll|1at the nicotinamide ring of NAD* is also pro-
`tra,
`
`isolating this NADD and using it in the reverse
`‘
`r
`°“°"°n to reduce normal acetaldehyde, the deuterium
`
`Page 6 of 8
`
`

`
`336 Chapter 12. Introduction to Enzymes
`
`hydrogen of ethanol to the re face of the nicotinamide ring
`of NAD* as is drawn in the preceding diagram.
`The slereospccrficity of YADH is by no means unusual.
`As we consider biochemical reactions we shall find that
`nearly all enzymes that participate in chiral reactions are
`absolute!y riereospecrjfic.
`
`Stereospeclficity In the NADH-Dependent
`Dehydrogennses May Have Functional Significance
`In our exploration of metabolism, we shall encounter
`numerous species of NADH-dependent dehydrogenases
`that function to reduce (or oxidize) a great variety of sub-
`strates These various dehydrogenases are more or less
`equally distributed between those transferring the pro-R
`(rekside) and the pro-S (31-side) hydrogens at C4 of NADH
`(also known as A-side and B-side transfers).
`
`cates that at least some of the side chains responsible rm.
`YADI-l’s stereospecilicity are not essential for catalysis and
`hence strengthens the argument that stereospecificity in me
`dehydrogenases has functional significance.
`
`B. Geometric Specificity
`
`The stereospecificity ofenzymes is not particularly SllI'p1-is.
`ing in light ofthe complementarity ofan enzymatic binding
`site for its substrate. A substrate of the wrong chirality will
`not fit into an enzymatic binding site for much the same
`reasons that you cannot fit your right hand into your lefi
`glove. In addition to their rrereospectficiry, however, mos,
`enzymas are quiteselective about the identities ofthe chem}.
`calgroups on their substrates. Indeed, such geometric spee.
`ificity is a more stringent requirement than is stereospeci.
`ficity. After all. your left glove will more or less fit left hand;
`that have somewhat different sizes and shapes than your
`own.
`
`Yet, despite the fact that sr'- and re-side hydrogen transfers
`to or from the nicotinarnide ring yield chemically identical
`products. a particular specificity of transfer is rigidly main-
`tained within classes of dehydrogenases catalyzing similar
`reactions in diflerent organisms. indeed, dehydrogenases
`that catalyze reactions whose equilibrium constants with
`their natural substrates in the direction of reduction are
`<l0‘”M almost always uansfer the nicotinamide‘s pro-R
`hydrogen, whereas those with equilibrium constants
`>l0"°M generally transfer the pro-S hydrogen. Why has
`evolution so assiduously maintained this stereospecilicity?
`Is it simply the result ofa historical accident or does it serve
`some physiological function?
`The NADH hydrogen transferred in a given enzymatic
`reaction is almost certainly that on the side of the nicotin-
`amide ring facing the substrate. It has therefore been widely
`assumed that the stereospecificity in any given class of de-
`hydrogenases simply arose through a random choice made
`early in evolutionary history. Once made, this choice be-
`came “locked in." because flipping a nicotinamide ring
`about its glycosidic bond in NADH would result, it was
`presumed, in its carboxarnide group obstructing catalyti-
`cally essential residues on the enzyme.
`in an effort to shed light on this matter, Steven Benner
`mutated YADH in a manner that the X-ray stmcture ofthe
`closely similar enzyme horse liver alcohol dehydrogenase
`(LAD!-I) suggests permits the 3:’ face of nicotinamide to
`bind to the enzyme without interfering with catalysis. The
`resulting mutant enzyme (Leu 182 - Ala) makes one
`stereochemical “mistalre" every 850,000 turnovers vs one
`mistake every 7 billion turnovers for wild-type (unmutated)
`YADH. This 8000-fold decrease in stereospecificity indi-
`
`_‘
`
`A
`
`._
`
`A
`
`j,
`. I
`
`‘
`
`I
`
`V‘
`
`Enzymes vary considerably in their degree ofgeometric
`specificity. A few enzymes are absolutely specific for only
`one compound. Most enzymes, however, catalyze the rear.
`tions ofa small range of related compounds. For example,
`YADH catalyzes the oxidation of small primary and sec-
`ondary alcohols to their corresponding aldehydcs or ice-
`tones but none so elliciently as that ofethanoL Even melll-
`anol or isopropanol, which difl‘er from ethanol only by the
`deletion or addition ofa CH, group, are oxidized by YADH
`at rates that are, respectively, 25-fold and 2.5-fold slower
`than that for ethanol. Similarly, NADP", which difl'ers
`from NAD‘* only by the addition ofa phosphoryl group at
`,
`the 2' position of its adenosine ribose group (Fig. I2-2),
`does not bind to YADH. On the other hand, there are many _-
`enzymes that bind NADP* but not NAD*.
`Some enzymes, particularly digestive enzymes, are so
`permissive in their ranges ofacceptable substrates that tbeif
`'
`geometric specilicities are more accurately described 815
`preferences. Carboxypeptidase A, for example, catalyzf-5 '
`the hydrolysis of C-terminal peptide bonds to all residues .
`except Arg, Lys, and Pro ifthe preceding residue is not P10
`(Table 6-1). However, the rate of this enzymatic reaction
`varies with the identities ofthe residues in the vicinity ofthe
`C-terminus ofthe polypeptide (see Fig. 6-5). Some enzym°5 ‘
`are not even very specific in the type of reaction they cal?‘
`lyze. Thus chymotrypsin, in addition to its ability to 11105"
`ate peptide bond hydrolysis. also catalyzes ester bond hi‘
`drolysis.
`0
`O
`II
`*
`[1
`ll
`no mm + I-I20 if-'-'L RC—0" + u
`Peptide
`
`. 5 '
`
`0
`0
`1
`ehymotrypsin
`I
`RC Oil + H20 —f>RC- 0' + HOR
`Ester
`H+
`
`Page 7 of 8
`
`

`
`T
`
`‘M the gcyl group acceptor in the chymotrypsin re-
`,
`e'd not be water: amino acids, alcohols. or ammo-
`‘
`;,1of°°
`action
`“£350 act in this capacity. it should be realized, how-
`l1 *
`M _
`’ niflwn [Such pcrmissiveness is much more the exception
`4
`lmmic, Indeed, most intracellular enzymes function
`
`.33 CQENZYMES
`:2.
`cs catalyze a wide variety of chemical reactions.
`iv" Enzyni-“notional groups can facilely participate in acid-
`Thwmctjons, form certain types of transient covalent
`based‘ and take part in charge—charge interactions (Sec-
`bag 14.1). They are, however. less suitable for catalyzing
`“idation-reduction reactions and many types of group-
`3:“ (dons, they can onlydo so in association with small mole-
`‘I'wk mfmogs, which essentially act as the enzymes
`~' Fciiemical teeth."
`_
`:‘ cofactor: may be metal ions. such as the Zn“ required
`"’ me catalytic activity ofcarboxypeptidase A, or organic
`_fi-iolecules known as coenzyines such as the NAD* in
`impfl (Section I2-2A). Some cofactors,
`for instance
`73 AD*, are but transiently associated with a given enzyme
`. molecule so that, in effect, they function as cosubstrates.
`"other cofactors, known as prosthetic groups. are essentially
`.314 H‘ ently associated with their protein. often by cova-
`Ei t bonds. For example, the heme prosthetic group of he-
`.globin is tightly bound to its protein through extensive
`liydrophobic and hydrogen bonding interactions together
`-with a covalent bond between the heme Fe“ ion and His F8
`~ . (Sections 9-IA and 28).
`1".‘ Coenzymes are chemically changed by the enzymatic re-
`«»_actions in which they participate. Thus. in order to com-
`
`. Tiii: CDI\ll\ION Cocuzvmss
`
`Reaction Mediated
`
`Section Discussed
`
`Carboxylation
`Alkylation
`
`Acyl transfer
`Ox idation-
`reduction
`Acyl transfer
`Oxidation-
`reduction
`Amino group
`tmnsfcr
`
`One-carbon group
`transfer
`Aldehyde transfer
`
`21- IA
`23-2E
`
`I9-2A
`I-1-4
`
`I9-2A
`I2-2A
`
`24-IA
`
`24-4D
`
`I6-3B
`
`.S’t't.'ti'tm I2-3. Cotvizymes 337
`
`plete the catalytic cycle. the coenzyme must be returned to
`its original state. For prosthetic groups, this can occur only
`in a separate phase ofthe enzymatic reaction sequence. For
`transiently bound coenzymes. such as NAD*, however, the
`regeneration reaction may be catalyzed by a different en-
`zymc.
`
`A catalytically active enzyme —cofactor complex is called
`a holoenzyme. The enzymatically inactive protein resulting
`from the removal of a holoenzyn1e’s cofactor is referred to
`as an apoenzyiiie; that is,
`
`apoenzyme (iiiaciive) + cofactor
`
`—-=2 holoenzyme (aaive)
`
`Table I2-I lists the most common coenzymes together
`with the types of reactions in which they participate. We
`shall describe the structures of these substances and their
`reaction mechanisms in the appropriate sections ofthe text.
`
`Many Vitamins Are Coenzyine Precursors
`Many organisms are unable to synthesize certain por-
`tions of essential cofactors and therefore these substances
`must be present in the organisms diet: thus they are vita-
`mins. In fact, many coenzymes were discovered as growth
`factors for microorganisms or substances that cure nutri-
`tional deficiency diseases in humans and animals For ex-
`ample, the NAD* component nicotlnainitle (alternatively
`known as niaeinamide) or its carboiiylic acid analog nico-
`tinic acid (niacin; Fig. I2-4), relieve the dietary deficiency
`disease in humans known as pellagra. Pellagi-.1. which is
`characterized by diarrhea. dermatitis. and dementia, was
`endemic in the rural Southern United States in the early
`twentieth century. Most animals. including humans, can
`synthesize nicotinamide from the amino acid tryptophan
`(Section 26-6A). The corn-rich diet that was prevalent in
`the rural South. however, contained little available nicotin-
`amide or tryptophan from which to synthesize it. [Corn
`actually contains significant quantities ofnicotinamide but
`in a fonn that requires treatment with base before it can be
`intestinally absorbed. The Mexiain Indians, who are
`thought to have domesticated the corn plant. customarily
`soak corn meal in lime water—dilute Ca(OH), solution -—
`before using it to bake their staple food, tortillas]
`
`0
`
`C\Nl~l.
`
`/
`
`I
`
`N
`Nicotintimido
`lniuclnnrnidcl
`
`I \ (1\Oll
`
`/
`
`N
`Nicntinic at.-id
`tniucinl
`
`FIGURE I2-4. The structures of nicotinamide and nicotinic
`acid. These vitamins form the redox-active components of the
`nicotinamide coenzymes NAD*' and NADP‘ (compare with Fig.
`12-2).
`
`Page 8 of 8

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket